Letter to the Editor
Sensitive and high sensitivity cardiac troponin I concentrations in the Heart Outcomes Prevention Evaluation (HOPE) study — A high risk population

https://doi.org/10.1016/j.cca.2010.07.001Get rights and content

Section snippets

Dear editor

A recent study utilizing a high-sensitivity cardiac troponin T (hs-cTnT) assay in a stable coronary artery disease (CAD) population indicated that > 10% of participants had elevations above the 99th percentile [1]. However, few data exist exploring the role of hs-cTnI in this setting. Schulz et al. begin to describe the performance of a pre-commercial hs-cTnI assay in a smaller population of patients (n = 222) with stable cardiovascular disease [2]. Their findings suggest that elevations in

Acknowledgement

This work was supported by the Canadian Institutes of Health Research with reagents provided as an unrestricted grant by Beckman Coulter. PK supported by an Early Researcher Award, Ministry of Research & Innovation, Government of Ontario.

References (5)

There are more references available in the full text version of this article.

Cited by (9)

  • Prognostic Value of High-Sensitivity Cardiac Troponin T Compared with Risk Scores in Stable Cardiovascular Disease

    2017, American Journal of Medicine
    Citation Excerpt :

    Risk scores have been shown to perform poorly when they are applied in a population who is not comparable to the original derivation cohort and when the baseline risk of the populations differs.31-33 In contrast, high-sensitivity cardiac troponin T has proved to be an excellent prognostic performance in other low-risk cohorts,34-36 in chronic heart failure,5 in asymptomatic high-risk patients,8 and in the general population.37-39 Therefore, high-sensitivity cardiac troponin T seems to be a more reliable risk predictor that may be applied in a broad spectrum of patients.

  • Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress

    2016, Canadian Journal of Cardiology
    Citation Excerpt :

    Further, NT-proBNP was the only marker, when added to a model of cardiovascular risk factors, to improve risk prediction for a recurrent cardiovascular event in a secondary-prevention population.28 In the recent past however, troponin as a sensitive indicator of myocardial damage was also shown to be a strong predictor of mortality in the same study cohort.3,4 The results of our study pointed to the use of the novel biomarker MR-proADM.8,10,11,13

View all citing articles on Scopus
View full text